Skip to main content
. 2013 Apr 19;8(4):e61494. doi: 10.1371/journal.pone.0061494

Table 2. Sample characteristics and task performance group × diagnosis.

Group; mean (SD)
PCLO+ PCLO−
MDD (N = 64) HC (N = 18) MDD (N = 25) HC (N = 11)
Sample characteristics
Gender (%female) 65.6% (n = 42) 50.0% (n = 9) 60% (n = 15) 63.6% (n = 7)
Age (years) 35.9 (9.57) 43.2 (10.05) 39.0 (11.38) 40.0 (9.12)
Education (years) 12.4 (3.24) 14.7 (2.78) 11.3 (2.85) 13.6 (2.16)
Scancenter (% A, L, G) 23.4, 46.9, 29.7 38.9, 33.3, 27.8 24, 36, 40 54.5, 36.4, 9.1
IDS (score) 24.3 (10.03) 3.9 (3.26) 22.1 (13.29) 3.7 (3.43)
MADRS (score) 16.8 (9.12) 1.5 (2.18) 14.4 (9.82) .27 (.65)
Duration SSRI use (months) 14.5 (19.76) N/A 32.0 (46.59) N/A
SSRI use (no/yes) 43/21 18/0 18/7 11/0
Memory performance (p)
pCREC.neg .693 (.143) .658 (.127) .700 (.118) .652 (.170)
pCREC.pos .724 (.129) .700 (.145) .728 (.143) .764 (.103)
pCREC.neu .702 (.163) .656 (.114) .717 (.175) .621 (.219)
pFA.all .123 (.084) .132 (.067) .129 (.078) .099 (.079)
pCREJ.neg .658 (.136) .668 (.143) .655 (.146) .718 (.161)
pCREJ.pos .696 (.165) .701 (.212) .713 (.165) .739 (.205)
pCREJ.neu .807 (.136) .846 (.106) .800 (.142) .884 (.083)
Response time (sec)
rt SCR.neg 1.28 (.32) 1.32 (.57) 1.26 (.26) 1.24 (.37)
rt SCR.pos 1.53 (.39) 1.35 (.31) 1.43 (.36) 1.45 (.26)
rt SCR.neu 1.59 (.39) 1.47 (.45) 1.52 (.32) 1.54 (.31)
rt CREJ.neg 1.51 (.32) 1.48 (.35) 1.44 (.42) 1.50 (.35)
rt CREJ.pos 1.56 (.34) 1.49 (.34) 1.50 (.37) 1.50 (.33)
rt CREJ.neu 1.41 (.31) 1.40 (.30) 1.37 (.37) 1.37 (.24)
rt CREC.neg 1.26 (.21) 1.33 (.30) 1.23 (.30) 1.29 (.25)
rt CREC.pos 1.36 (.27) 1.42 (.31) 1.31 (.29) 1.30 (.24)
rt CREC.neu 1.31 (.25) 1.43 (.30) 1.31 (.31) 1.40 (.35)

Sample characteristics and task performance of the total sample, divided into genotype × diagnosis. SD: standard deviation; n:number of participants; PCLO+: PCLO risk allele carriers; PCLO−: PCLO non-risk allele carries; A: Amsterdam; L: Leiden; G:Groningen; MDD: major depressive disorder; HC: healthy controls; IDS: Inventory of Depressive Symptomatology; MADRS: Montgomery-Åsberg Depression Rating Scale; SSRI: Selective Serotonin Reuptake Inhibitors; p: proportion correct answers; neg: negative (words); pos: positive (words); neu: neutral (words); sec: seconds; rt: response time.

Mean proportion correct and response times for encoding (subsequent hits) and recognition (hits, false alarms, correct rejection) indices. Correct RECognition (CREC): correct recognition of a previously encoded word; False Alarm (FA): incorrect indication of a newly presented word as a previously encoded word; Correct REJection (CREJ): correct recognition of a newly presented word as a new word; Subsequent Correct Recognition (SCR): consists of a word, presented during the encoding phase, that is correctly recognized during the subsequent recognition phase.